Y-Mabs Therapeutics OverviewY-Mabs Therapeutics Net Income
Profitability analysis for YMAB.
Quarterly Net Income
-$3.24M
↑ 64.98% YoY
As of Jun 2025
Annual Net Income (TTM)
-$22.22M
↑ 9.71% YoY
Trailing 12 months ending Jun 2025
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...